Nephrostomy Devices Market

Nephrostomy Devices Market Analysis

The Nephrostomy Devices Market is expected to register a CAGR of 7.8% during the forecast period.

• COVID-19 significantly impacted the nephrostomy devices market during the initial wave since many of the nephrology-related surgeries and consultations were delayed due to the global lockdown. For instance, as per the article published in December 2021 in PubMed, the COVID-19 epidemic pushed urology departments around the world to restructure care due to inadequate resources and personnel. Hence, the nephrostomy devices market was impacted by the pandemic. However, as the restrictions are relaxed, the market is expected to witness growth in the coming years due to the increase in kidney diseases and the rise in the adoption of nephrostomy devices.
• Factors such as an increase in kidney diseases, a rise in demand for minimally invasive surgeries, and technological advances in nephrostomy devices are expected to drive market growth over the forecast period. For instance, as per the American Cancer Society 2023 cancer statistics, about 81,800 new cases of kidney cancer are estimated to be diagnosed in the United States in 2023. This figure was an increase from 79,000 cases in 2022.
• Hence, the high prevalence of kidney diseases is likely to increase the demand for nephrostomy devices since people with cancer may need a nephrostomy if there is a blockage in the urinary system, thereby driving market growth over the forecast period. The demand for minimally invasive surgeries(MIS) is also one of the major factors driving the market growth over the forecast period. For instance, as per the article published in September 2022 in JAMA Network, compared with open surgery, minimally invasive surgery has been found to have a shorter length of hospital stay, reduced blood loss, lower rates of postoperative morbidity, reduced operative pain, improved cosmesis, and equivalent oncological outcomes. Hence, considering the advantages offered by MIS in nephrostomy, the demand for Nephrostomy devices is likely to increase over the forecast period.
• Hence, increasing cases of kidney diseases, and rise in demand for minimally invasive surgical procedures, and increased awareness about the product are the key driving factors in the nephrostomy devices market. However, the rise in alternative procedures and risks associated with nephrostomy is expected to restrain the market growth over the forecast period.

Nephrostomy Devices Market Trends

Guidewires Segment is Expected to Hold a Significant Market Share in the Market Over the Forecast Period

• A guidewire is a useful tool for obtaining access to and facilitating passage through various luminal structures. Urological guidewires are intended to facilitate the placement of endourological instruments during diagnostic or interventional procedures. The guidewire segment is expected to drive market growth due to the increase in kidney complications and the rise in demand for minimally invasive producers of kidney diseases.
• For instance, as per the article published in November 2022 in BMJ journal, for the post-operative ureteral injury after cytoreductive surgery for ovarian cancer, the minimally invasive approach can facilitate early recovery and avoid delays in adjuvant treatments. Due to the increase in the utilization of guidewires in nephrostomy minimally invasive surgeries, the segment is expected to witness significant growth over the forecast period.
• Increasing cases of kidney stone disorder, increasing prevalence of ovarian, bladder, and prostate cancers, and rise in demand for minimally invasive surgical procedures are the key driving factors in the guidewires segment. For instance, as per the American Cancer Society 2023 statistics, about 19,710 women are likely to be diagnosed with ovarian cancer in the United States in 2023.
• According to the same source, the United States is anticipated to have 82,290 new cases of bladder cancer in 2023. Hence, the high prevalence of bladder and ovarian cancer is expected to increase the need for guidewires to conduct nephrostomy, thereby likely boosting the market growth over the forecast period.

North America is Expected to Hold a Significant Share in the Market Over the Forecast Period

• North America is expected to hold a significant market share in the nephrostomy devices market due to an increase in cases of kidney diseases, a rise in demand for minimally invasive surgical procedures, a surge in healthcare expenditure, and the availability of skilled surgeons in this region.
• For instance, as per the Kidney Foundation Canada, kidney stones are common in Canada and appear to be on the rise, especially over the last 25 years. About 12% of men and 6% of women will have a kidney stone at some point in their life. In men, the first kidney stone is usually diagnosed between the ages of 40 and 60. For women, it is somewhat younger, between about 25 and 30 years of age.
• Also, as per the research report published by Kidney Foundation in 2021, Diabetes is the leading cause of kidney failure in Canada. In November 2021, the Kidney Foundation of Canada invested USD 1 million for research that will address the prevention of kidney failure for people with Type 1 diabetes. Funds are matched by the Canadian Institutes of Health Research (CIHR) through a groundbreaking initiative: Team Grants in Diabetes Mechanisms and Translational Solutions.
• Furthermore, the rise in the prevalence of kidney stones in the studied region is expected to increase the demand for nephrostomy devices. For instance, as per the article published in April 2022 in PubMed, the prevalence of kidney stones among the population was 2,054 stones per 100,000 adults in the United States. The study identified a significant relationship between stone incidence and subject age, body mass index, race, and history of hypertension.
• Hence, due to the increase in cases of kidney diseases and a rise in research and development investments, North America is estimated to hold a notable market share over the forecast period.

Nephrostomy Devices Industry Overview

The nephrostomy devices market is fragmented and consists of several major players. In terms of market share, a few of the major players are currently dominating the market. Some of the key companies in the market are Boston Scientific Corporation, Teleflex Incorporated, Cardinal Health, Becton, Dickinson and Company, and B. Braun SE, among others.

Nephrostomy Devices Market Leaders

Nephrostomy Devices Market News

• January 2023: The University of Texas Health Science Center, Houston, revealed its plan to sponsor a clinical study to compare relevant clinical outcomes in patients requiring percutaneous nephrostomy for urolithiasis treatment between those who undergo an antegrade approach versus a retrograde approach and to determine which clinical characteristics predict the success of lithotomy with anterograde or retrograde percutaneous nephrostomy approaches.
• December 2022: CATHETRIX, an innovative developer of urinary (Foley) smart catheter fixation devices, launched its catheter stabilizer for the prevention of urinary tract infections (UTIs) and accidental Foley catheter extractions at the Arab Health 2023, which took place on January 30-February 2, 2023, in Dubai, UAE.